drugset / Trial / NCT00644670

A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol

NCT00644670 ↗

Phase 4 Completed 232 enrolled Viatris Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the effectiveness of atorvastatin in lowering cholesterol and getting these high risk patients to their goals of LDL \<115 mg/dl across starting doses of 10 mg, 20 mg, or 40 mg with one step titration.

Timeline

Start
2003-06
Primary completion
—
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg Oral
Subject Atorvastatin Small molecule 20 mg Oral
Subject Atorvastatin Small molecule 40 mg Oral

Indications